Minerva Surgical Inc. (UTRS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Minerva Surgical Inc. (UTRS:NASDAQ), powered by AI.

Current Price
$0.00
Market Cap
144
Sector
Healthcare
What is the Minerva Surgical Inc. stock price forecast?

Minerva Surgical Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Minerva Surgical Inc. insider trading activity?

View the latest insider trading data for Minerva Surgical Inc. on Alpha Lenz.

What is Minerva Surgical Inc.'s P/E ratio?

View Minerva Surgical Inc.'s valuation metrics on Alpha Lenz.

Minerva Surgical Inc.

NASDAQ · UTRS
$0.00+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Minerva Surgical Inc.'s future dividend policy...
Alpha Chat Insight

Minerva Surgical Inc.'s ROE is -111.3%. Explore profitability and growth together.

Ask for details

Company Overview

Minerva Surgical Inc. is a medical technology company specializing in the development, manufacturing, and commercialization of minimally invasive devices for women's uterine health. Its primary focus is on providing advanced solutions for the treatment of abnormal uterine bleeding (AUB), a prevalent condition that can significantly impact women's quality of life. Minerva Surgical offers a comprehensive suite of products, including endometrial ablation systems and advanced tissue removal devices, designed as alternatives to more invasive procedures like hysterectomy. These products utilize technologies such as bipolar radiofrequency energy and enable direct intrauterine visualization, supporting safer and more precise treatments in a variety of care settings, from hospitals to physician offices. By prioritizing uterus-sparing and non-hormonal interventions, Minerva Surgical aims to address the root causes of AUB while minimizing recovery time and preserving reproductive anatomy. The company's commitment to clinical excellence, innovation, and support for gynecologic practitioners positions it as a significant player in women’s health and the broader medical device sector.

CEOMr. Todd Usen
SectorHealthcare
IndustryMedical Devices
Employees174

Company Statistics

FY 2022

Profile

$144.00Market Cap
$50.29MRevenue
0.00Shares Out
174Employees

Margins

54.17%Gross
-39.91%EBITDA
-61.44%Operating
-67.80%Pre-Tax
-67.83%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
-1.63EV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-37.08%ROA
-111.32%ROE
-33.57%ROIC

Financial Health

$6.94MCash & Cash Equivalents
$44.78MNet Debt
301.02%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Minerva Surgical Inc. (ticker: UTRS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 174 employees. Market cap is $144.

The current price is $0 with a P/E ratio of -x and P/B of -x.

ROE is -111.32% and operating margin is -61.44%. Annual revenue is $50M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Minerva Surgical Inc. (UTRS) Stock Forecast 2026 $0.00 — Price, Financials & Analyst Targets | Alpha Lenz